Anti LP40 antibody, subclass IgG4

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	14

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 10 of 14 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2010-022101-18-HR (EUCTR)	31/03/2014	17/10/2014	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 17.0;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: Not available Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	Serbia;United States;Belarus;Philippines;Taiwan;Ecuador;Thailand;Spain;Ukraine;Russian Federation;Is ...
2	EUCTR2010-022101-18-DE (EUCTR)	20/03/2013	10/12/2012	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.1;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	United States;Belarus;Serbia;Philippines;Taiwan;Ecuador;Thailand;Spain;Ukraine;Israel;Chile;Russian ...
3	EUCTR2010-022101-18-GB (EUCTR)	21/12/2012	28/11/2012	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.1;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 INN or Proposed INN: Not available Other descriptive na ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	United States;Belarus;Serbia;Philippines;Taiwan;Ecuador;Thailand;Spain;Ukraine;Israel;Chile;Russian ...
4	EUCTR2010-022101-18-BG (EUCTR)	28/08/2012	29/08/2012	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 17.0;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	Serbia;United States;Belarus;Philippines;Taiwan;Ecuador;Thailand;Spain;Ukraine;Russian Federation;Is ...
5	EUCTR2010-022101-18-HU (EUCTR)	17/08/2012	17/05/2012	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.0;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	South Africa;Latvia;Tunisia;Korea, Democratic People's Republic of;Guatemala;Turkey;Austria;United K ...
6	EUCTR2010-022101-18-LV (EUCTR)	10/08/2012	28/05/2012	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.0;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	Serbia;United States;Belarus;Philippines;Taiwan;Ecuador;Thailand;Spain;Ukraine;Israel;Chile;Russian ...
7	EUCTR2010-022101-18-ES (EUCTR)	25/05/2012	21/05/2012	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 14.1;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	Serbia;United States;Belarus;Philippines;Taiwan;Ecuador;Thailand;Spain;Ukraine;Israel;Russian Federa ...
8	EUCTR2010-022101-18-AT (EUCTR)	14/05/2012	11/04/2012	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3b, Multicenter, Open-Label Study to Evaluate the Long-Term Safety and Efficacy of Subcutane ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 14.1;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1276	Phase 3	United States;Serbia;Belarus;Philippines;Taiwan;Ecuador;Thailand;Spain;Ukraine;Russian Federation;Ch ...
9	EUCTR2010-022099-29-DE (EUCTR)	04/07/2011	14/12/2010	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 16.1;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1140	Phase 3	United States;Belarus;Philippines;Thailand;Ukraine;Guatemala;Turkey;Austria;Chile;Colombia;Italy;Egy ...
10	EUCTR2010-022099-29-BG (EUCTR)	16/06/2011	24/02/2011	Study investigating a new medicine, LY2127399, in patients diagnosed with Systemic Lupus Erythematos ...	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy ...	Systemic Lupus Erythematosus (SLE) MedDRA version: 17.0;Level: LLT;Classification code 10025139;Term ...	Product Name: LY2127399 Product Code: LY2127399 Other descriptive name: LA294; Anti LP40 antibody, sub ...	Eli Lilly and Company	NULL	Not Recruiting			Female: yes Male: yes	1140	Phase 3	United States;Belarus;Philippines;Thailand;Guatemala;Ukraine;Turkey;Austria;Chile;Colombia;Italy;Egy ...

First Previous1 2Next Last